Research Database

18 studies found

Positive

66.7%

Negative

33.3%

Inconclusive

0.0%

Page 1 of 1

NegativeReview/Other

Sudden Cardiac Arrest in Patient With Ventricular Septal Defect and Marijuana Consumption: A Case Report and Review of Literature

2023

Cardiovascular Diseases (CVD)Heart AttackAtherosclerosis+7

PositiveAnimal Study - Veterinary Clinical Trial

Resolvin E1 heals injured cardiomyocytes: Therapeutic implications and H-FABP as a readout for cardiovascular disease & systemic inflammation

2023

Cardiovascular Diseases (CVD)

NegativeReview/Other

Hypertensive Crisis-Related Hospitalizations and Subsequent Major Adverse Cardiac Events in Young Adults with Cannabis Use Disorder: A Nationwide Analysis

2022

Addiction - Cannabis

NegativeMeta-analysis -

Adverse Effects of Cannabinoids and Tobacco Consumption on the Cardiovascular System: A Systematic Review

2022

Addiction - Nicotine

PositiveAnimal Study -

Olfactory Stimulation with Volatile Aroma Compounds of Basil ( Ocimum basilicum L.) Essential Oil and Linalool Ameliorates White Fat Accumulation and Dyslipidemia in Chronically Stressed Rats

2022

Atherosclerosis

PositiveAnimal Study -

Fatty Acid Amide Hydrolase Deficiency Is Associated with Deleterious Cardiac Effects after Myocardial Ischemia and Reperfusion in Mice

2022

Cardiovascular Diseases (CVD)

PositiveReview/Other

Medicinal Herbs in the Relief of Neurological, Cardiovascular, and Respiratory Symptoms after COVID-19 Infection A Literature Review

2022

COVID-19

NegativeAnimal Study - Veterinary Clinical Trial

Synthetic Cannabinoids and Cathinones Cardiotoxicity: Facts and Perspectives

2021

Poisoning by Synthetic Cannabis

PositiveReview/Other

Peripheral Endocannabinoids Associated With Energy Expenditure in Native Americans of Southwestern Heritage

2018

Metabolic Syndrome

PositiveReview/Other

The Protective Cardiac Effects of β-Myrcene After Global Cerebral ıschemia/Reperfusion in C57BL/J6 Mouse

2016

Cardiovascular Diseases (CVD)

NegativeReview/Other

Effect of Carvedilol on Serum Heart-type Fatty Acid-binding Protein, Brain Natriuretic Peptide, and Cardiac Function in Patients With Chronic Heart Failure

2015

Cardiovascular Diseases (CVD)

NegativeReview/Other

Combination of biomarkers for diagnosis of acute kidney injury after cardiopulmonary bypass

2015

Cardiovascular Diseases (CVD)

PositiveLaboratory Study -

Molecular basis for the improvement in muscle metaboreflex and mechanoreflex control in exercise-trained humans with chronic heart failure

2014

Cardiovascular Diseases (CVD)

PositiveReview/Other

Ligand activation of cannabinoid receptors attenuates hypertrophy of neonatal rat cardiomyocytes.

2014

Cardiac Arrhythmias

PositiveReview/Other

An ultra-low dose of tetrahydrocannabinol provides cardioprotection.

2013

Cardiovascular Diseases (CVD)

PositiveClinical Trial

Potential benefit of statin therapy for dyslipidemia with chronic kidney disease: Fluvastatin Renal Evaluation Trial (FRET)

2011

Chronic Kidney Disease

PositiveReview/Other

Cannabidiol, a nonpsychoactive Cannabis constituent, protects against myocardial ischemic reperfusion injury.

2007

Cardiovascular Diseases (CVD)

PositiveAnimal Study - Veterinary Clinical Trial

The endogenous cardiac cannabinoid system: a new protective mechanism against myocardial ischemia.

2006

Cardiovascular Diseases (CVD)

Command Palette

Research Database

Sudden Cardiac Arrest in Patient With Ventricular Septal Defect and Marijuana Consumption: A Case Report and Review of Literature

Resolvin E1 heals injured cardiomyocytes: Therapeutic implications and H-FABP as a readout for cardiovascular disease & systemic inflammation

Hypertensive Crisis-Related Hospitalizations and Subsequent Major Adverse Cardiac Events in Young Adults with Cannabis Use Disorder: A Nationwide Analysis

Adverse Effects of Cannabinoids and Tobacco Consumption on the Cardiovascular System: A Systematic Review

Olfactory Stimulation with Volatile Aroma Compounds of Basil ( Ocimum basilicum L.) Essential Oil and Linalool Ameliorates White Fat Accumulation and Dyslipidemia in Chronically Stressed Rats

Fatty Acid Amide Hydrolase Deficiency Is Associated with Deleterious Cardiac Effects after Myocardial Ischemia and Reperfusion in Mice

Medicinal Herbs in the Relief of Neurological, Cardiovascular, and Respiratory Symptoms after COVID-19 Infection A Literature Review

Synthetic Cannabinoids and Cathinones Cardiotoxicity: Facts and Perspectives

Peripheral Endocannabinoids Associated With Energy Expenditure in Native Americans of Southwestern Heritage

The Protective Cardiac Effects of β-Myrcene After Global Cerebral ıschemia/Reperfusion in C57BL/J6 Mouse

Effect of Carvedilol on Serum Heart-type Fatty Acid-binding Protein, Brain Natriuretic Peptide, and Cardiac Function in Patients With Chronic Heart Failure

Combination of biomarkers for diagnosis of acute kidney injury after cardiopulmonary bypass

Molecular basis for the improvement in muscle metaboreflex and mechanoreflex control in exercise-trained humans with chronic heart failure

Ligand activation of cannabinoid receptors attenuates hypertrophy of neonatal rat cardiomyocytes.

An ultra-low dose of tetrahydrocannabinol provides cardioprotection.

Potential benefit of statin therapy for dyslipidemia with chronic kidney disease: Fluvastatin Renal Evaluation Trial (FRET)

Cannabidiol, a nonpsychoactive Cannabis constituent, protects against myocardial ischemic reperfusion injury.

The endogenous cardiac cannabinoid system: a new protective mechanism against myocardial ischemia.